-86%

est. 2Y upside i

HealthcareSeed

Stellar Sleep uses psychology to help the 25 million Americans with chronic insomnia who are getting inadequate and superficial care advice.

Rank

#807

Sector

Digital Health, Healthcare

Est. Liquidity

~7Y

Data Quality

Data: Medium

Stellar Sleep is an early-stage digital health company with a promising psychology-based treatment for chronic insomnia in a growing market.

Last updated: March 10, 2026

Bull (30%)+400%

Stellar Sleep achieves significant market penetration through successful B2B partnerships and superior clinical outcomes, driving ARR to $25M within two years. This growth attracts an acquisition by a major digital health platform or healthcare provider at a $120M valuation (4.8x future ARR), representing a 400% return on the current estimated $30M valuation.

Base (25%)+50%

Stellar Sleep maintains steady growth, reaching $6M ARR in two years, but faces increasing competition and moderate customer acquisition costs. The company secures a Series A round or is acquired for its technology and user base at a $45M valuation, providing a 50% return on the current $30M valuation.

Bear (45%)-80%

Stellar Sleep struggles to differentiate itself amidst intense competition from well-funded incumbents like Sleepio and Headspace, and fails to scale beyond $2M ARR. This leads to a down round or asset sale at $6M, resulting in an 80% loss for common stock holders after liquidation preferences.

Est. time to liquidity~7.0 years

Preference Stack Risk

high

Investors hold $6M in liquidation preferences, meaning common shareholders would only see returns after this amount is paid out in an exit at or above $6M.

Dilution Risk

high

As a seed-stage company, Stellar Sleep will need to raise multiple additional funding rounds (Series A, B, C, etc.), which will lead to significant dilution for early employees.

Secondary Liquidity

none

Given its early stage, there is currently no active secondary market or tender offers for Stellar Sleep equity.

Questions to Ask at the Interview

Strategic questions based on Stellar Sleep's data — designed to show you've done your homework.

  • 1

    How is Stellar Sleep planning to differentiate its CBT-I solution from established competitors like Sleepio and Headspace, especially given their larger resources and existing user bases?

  • 2

    With $1M ARR and recent seed funding, what are the key milestones and growth strategies for reaching profitability or securing a successful Series A round within the next 18-24 months?

  • 3

    Given the early stage and the need for future funding, how does the company communicate potential dilution to employees, and what is the long-term vision for employee equity liquidity?

Community

Valuation Sentiment

Our model estimates -86% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.